相似文献
1
Selling drugs to doctors--it's marketing, not education.
Br J Gen Pract. 2002 Feb;52(475):168-9.
2
Selling drugs to the public--should the UK follow the example of the US?
Br J Gen Pract. 2002 Feb;52(475):170-1.
3
[Rules of the game in drug marketing].
Duodecim. 1999;115(20):2187, 2189.
4
The role of direct-to-consumer advertising.
Manag Care Interface. 1998 Nov;11(11):79-80, 82.
5
Pharmaceuticals and medical devices: FDA oversight.
Issue Brief Health Policy Track Serv. 2013 Dec 30:1-123.
6
7
Direct-to-consumer genetic tests, government oversight, and the First Amendment: what the government can (and can't) do to protect the public's health.
Oklahoma Law Rev. 2004 Summer;57(2):251-302.
8
An insider's perspective: defense of the pharmaceutical industry's marketing practices.
Albany Law Rev. 2012;76(1):299-334.
9
Major issues in marketing regulation.
Food Drug Law J. 1997;52(3):297-302.
10
Marketing pharmaceuticals: a constitutional right to sell prescriber-identified data?
JAMA. 2012 Feb 22;307(8):787-8. doi: 10.1001/jama.2012.182.
引用本文的文献
1
Selling drugs to the public--should the UK follow the example of the US?
Br J Gen Pract. 2002 Feb;52(475):170-1.
本文引用的文献
1
Selling drugs to the public--should the UK follow the example of the US?
Br J Gen Pract. 2002 Feb;52(475):170-1.
2
Lotronex and the FDA: a fatal erosion of integrity.
Lancet. 2001 May 19;357(9268):1544-5. doi: 10.1016/S0140-6736(00)04776-0.
3
Evidence-based advertising? A survey of four major journals.
J Am Board Fam Pract. 2001 May-Jun;14(3):197-200.
4
Do drug company promotions influence physician behavior?
West J Med. 2001 Apr;174(4):232-3. doi: 10.1136/ewjm.174.4.232.
5
Direct-to-consumer promotion of prescription drugs. Economic implications for patients, payers and providers.
Pharmacoeconomics. 2001;19(2):109-19. doi: 10.2165/00019053-200119020-00001.
6
The pharmaceutical industry--to whom is it accountable?
N Engl J Med. 2000 Jun 22;342(25):1902-4. doi: 10.1056/NEJM200006223422509.
7
Reasons for not seeing drug representatives.
BMJ. 1999 Jul 10;319(7202):69-70. doi: 10.1136/bmj.319.7202.69.
8
Trends in antihypertensive drug advertising, 1985-1996.
Circulation. 1999 Apr 20;99(15):2055-7. doi: 10.1161/01.cir.99.15.2055.
9
Regulating pharmaceutical advertising: what will work?
CMAJ. 1997 Feb 1;156(3):359-61.
10
Why would anyone have expected anything else? Characteristics of materials distributed by drug companies: four points of view.
J Gen Intern Med. 1996 Oct;11(10):640-1. doi: 10.1007/BF02599034.
Zotero 插件